Amgen Stock Has Surged. Here’s Where It’s Headed Next.
But this week, the stock jumped again after Amgen issued a strong financial update Tuesday. Its rise helped push up the S&P ...
Amgen: The Charts Didn't Lie, Upgrade To Buy
Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...
OpenAI’s rebrand tries to tap into the emotional side of AI
OpenAI's rebrand balances the technical and the emotional by updating its logo and centering a new typeface called OpenAI ...
Amgen Inc. (NASDAQ:AMGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations were $5.04. Operator: My name is Julienne, and I will be your conference ...
Amgen price target raised to $275 from $256 at BofA
BofA raised the firm’s price target on Amgen (AMGN) to $275 from $256 and keeps an Underperform rating on the shares. Q4 results were slightly ...
Amgen Q4 Earnings: Good Quarter, Ok Guidance, But MariTide Concerns Me (Rating Downgrade)
Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.
Evercore ISI Reaffirms Their Buy Rating on Merck & Company (MRK)
In a report released yesterday, Umer Raffat from Evercore ISI maintained a Buy rating on Merck & Company (MRK – Research Report). The ...